Report Details
Not found what are you looking for
Pharma & Healthcare
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2022 Professional Edition
Description
ToC
Tables & Figures
Companies
Speak with Analyst
Report Overview
The global Radiopharmaceuticals in Nuclear Medicine market was valued at 5060.37 Million USD in 2021 and will grow with a CAGR of 4.93% from 2021 to 2027, based on the newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market Vendors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Vendors:
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
By Types:
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
By Applications:
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Key Indicators Analysed:
Market Players & Competitor Analysis:
The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on Vendors and comprehensive details of factors that will challenge the growth of major market Vendors.
Global and Regional Market Analysis:
The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends:
Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers:
Identifying the Growing Demands and New Technology
Porters Five Force Analysis:
The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase:
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
FAQ
- You should buy this report from Xcellent Insights for a better clarity on market scenarios.
- The market report has been prepared using a pragmatic approach to suit your needs.
- We have an extensive library of reports that can help you understand the market landscape and make informed decisions about your business.
- Additionally, the reports are written by experienced analysts who have a deep understanding of the market and the latest trends.
- Besides, customization is a value-added service if you decide to opt.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Radiopharmaceuticals in Nuclear Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Diagnostic Radiopharmaceuticals
1.4.3 Therapy Radiopharmaceuticals
1.4.4 Enriched Stable Isotopes
1.5 Market by Application
1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application: 2022-2027
1.5.2 Diagnostic Application
1.5.3 Therapeutic Application
1.5.4 Research
1.5.5 Pharmaceutical
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Radiopharmaceuticals in Nuclear Medicine Market
1.8.1 Global Radiopharmaceuticals in Nuclear Medicine Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Region (2016-2021)
3.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Market Share by Region (2016-2021)
3.3 North America Radiopharmaceuticals in Nuclear Medicine Sales Volume
3.3.1 North America Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.3.2 North America Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume
3.4.1 East Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume (2016-2021)
3.5.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume (2016-2021)
3.6.1 South Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume (2016-2021)
3.7.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume (2016-2021)
3.8.1 Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume (2016-2021)
3.9.1 Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Radiopharmaceuticals in Nuclear Medicine Sales Volume (2016-2021)
3.10.1 Oceania Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Radiopharmaceuticals in Nuclear Medicine Sales Volume (2016-2021)
3.11.1 South America Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.11.2 South America Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Radiopharmaceuticals in Nuclear Medicine Sales Volume (2016-2021)
3.12.1 Rest of the World Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Radiopharmaceuticals in Nuclear Medicine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Radiopharmaceuticals in Nuclear Medicine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Radiopharmaceuticals in Nuclear Medicine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Radiopharmaceuticals in Nuclear Medicine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Radiopharmaceuticals in Nuclear Medicine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Radiopharmaceuticals in Nuclear Medicine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Radiopharmaceuticals in Nuclear Medicine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (2016-2021)
14.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Market Share by Type (2016-2021)
14.3 Global Radiopharmaceuticals in Nuclear Medicine Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Application (2016-2021)
15.2 Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Radiopharmaceuticals in Nuclear Medicine Business
16.1 Bracco Imaging S.P.A.
16.1.1 Bracco Imaging S.P.A. Company Profile
16.1.2 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Specification
16.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Cambridge Isotope Laboratories, Inc.
16.2.1 Cambridge Isotope Laboratories, Inc. Company Profile
16.2.2 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
16.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Cardinal Health, Inc.
16.3.1 Cardinal Health, Inc. Company Profile
16.3.2 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
16.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Covidien, Plc
16.4.1 Covidien, Plc Company Profile
16.4.2 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Specification
16.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Eczacibasi-Monrol
16.5.1 Eczacibasi-Monrol Company Profile
16.5.2 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Specification
16.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Fujifilm Holdings Corporation
16.6.1 Fujifilm Holdings Corporation Company Profile
16.6.2 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Specification
16.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 GE Healthcare (Subsidiary Of General Electric Company)
16.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Profile
16.7.2 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Specification
16.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 IBA Group
16.8.1 IBA Group Company Profile
16.8.2 IBA Group Radiopharmaceuticals in Nuclear Medicine Product Specification
16.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Isotec, Inc. (Sigma-Aldrich)
16.9.1 Isotec, Inc. (Sigma-Aldrich) Company Profile
16.9.2 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Specification
16.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Lantheus Medical Imaging, Inc.
16.10.1 Lantheus Medical Imaging, Inc. Company Profile
16.10.2 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
16.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Nordion, Inc.
16.11.1 Nordion, Inc. Company Profile
16.11.2 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
16.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Ntp Radioisotopes (Pty), Ltd.
16.12.1 Ntp Radioisotopes (Pty), Ltd. Company Profile
16.12.2 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Specification
16.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Siemens Healthcare (Subsidiary Of Siemens AG)
16.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Company Profile
16.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Specification
16.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Taiyo Nippon Sanso Corporation
16.14.1 Taiyo Nippon Sanso Corporation Company Profile
16.14.2 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Specification
16.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Urenco Limited
16.15.1 Urenco Limited Company Profile
16.15.2 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Specification
16.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Rotem Industries, Ltd., Inc.
16.16.1 Rotem Industries, Ltd., Inc. Company Profile
16.16.2 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
16.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Australian Nuclear Association And Technology Organization (ANSTO)
16.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Company Profile
16.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Specification
16.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 Board of Radiation And Isotope Technology (BRIT)
16.18.1 Board of Radiation And Isotope Technology (BRIT) Company Profile
16.18.2 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Specification
16.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.19 Institute of Atomic Energy Polatom Radioisotope Centre
16.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Company Profile
16.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Specification
16.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.20 Institute of Isotopes Co., Ltd.
16.20.1 Institute of Isotopes Co., Ltd. Company Profile
16.20.2 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Specification
16.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.21 Institute Of Radioelement (IRE)
16.21.1 Institute Of Radioelement (IRE) Company Profile
16.21.2 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Specification
16.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Radiopharmaceuticals in Nuclear Medicine Manufacturing Cost Analysis
17.1 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
17.4 Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Radiopharmaceuticals in Nuclear Medicine Distributors List
18.3 Radiopharmaceuticals in Nuclear Medicine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Radiopharmaceuticals in Nuclear Medicine (2022-2027)
20.2 Global Forecasted Revenue of Radiopharmaceuticals in Nuclear Medicine (2022-2027)
20.3 Global Forecasted Price of Radiopharmaceuticals in Nuclear Medicine (2016-2027)
20.4 Global Forecasted Production of Radiopharmaceuticals in Nuclear Medicine by Region (2022-2027)
20.4.1 North America Radiopharmaceuticals in Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Radiopharmaceuticals in Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.3 Europe Radiopharmaceuticals in Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Radiopharmaceuticals in Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Radiopharmaceuticals in Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.7 Africa Radiopharmaceuticals in Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Radiopharmaceuticals in Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.9 South America Radiopharmaceuticals in Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Radiopharmaceuticals in Nuclear Medicine Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Radiopharmaceuticals in Nuclear Medicine by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Radiopharmaceuticals in Nuclear Medicine by Country
21.2 East Asia Market Forecasted Consumption of Radiopharmaceuticals in Nuclear Medicine by Country
21.3 Europe Market Forecasted Consumption of Radiopharmaceuticals in Nuclear Medicine by Countriy
21.4 South Asia Forecasted Consumption of Radiopharmaceuticals in Nuclear Medicine by Country
21.5 Southeast Asia Forecasted Consumption of Radiopharmaceuticals in Nuclear Medicine by Country
21.6 Middle East Forecasted Consumption of Radiopharmaceuticals in Nuclear Medicine by Country
21.7 Africa Forecasted Consumption of Radiopharmaceuticals in Nuclear Medicine by Country
21.8 Oceania Forecasted Consumption of Radiopharmaceuticals in Nuclear Medicine by Country
21.9 South America Forecasted Consumption of Radiopharmaceuticals in Nuclear Medicine by Country
21.10 Rest of the world Forecasted Consumption of Radiopharmaceuticals in Nuclear Medicine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Key Players Covered: Ranking by Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) 2016-2021
Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type (US$ Million): 2022-2027
Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application (US$ Million): 2022-2027
Global Radiopharmaceuticals in Nuclear Medicine Production Capacity by Manufacturers
Global Radiopharmaceuticals in Nuclear Medicine Production by Manufacturers (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Manufacturers (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturers (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2016-2021)
Global Market Radiopharmaceuticals in Nuclear Medicine Average Price of Key Manufacturers (2016-2021)
Manufacturers Radiopharmaceuticals in Nuclear Medicine Production Sites and Area Served
Manufacturers Radiopharmaceuticals in Nuclear Medicine Product Type
Global Radiopharmaceuticals in Nuclear Medicine Sales Volume by Region (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Region (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue by Region (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Market Share by Region (2016-2021)
North America Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
East Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Oceania Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
South America Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
Rest of the World Radiopharmaceuticals in Nuclear Medicine Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
North America Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2016-2021)
East Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2016-2021)
Europe Radiopharmaceuticals in Nuclear Medicine Consumption by Region (2016-2021)
South Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2016-2021)
Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2016-2021)
Middle East Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2016-2021)
Africa Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2016-2021)
Oceania Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2016-2021)
South America Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2016-2021)
Rest of the World Radiopharmaceuticals in Nuclear Medicine Consumption by Countries (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Sales Volume by Type (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue by Type (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Share by Type (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Sales Price by Type (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume by Application (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume Market Share by Application (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Consumption Value by Application (2016-2021)
Global Radiopharmaceuticals in Nuclear Medicine Consumption Value Market Share by Application (2016-2021)
Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
IBA Group Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Urenco Limited Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Radiopharmaceuticals in Nuclear Medicine Distributors List
Radiopharmaceuticals in Nuclear Medicine Customers List
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2022-2027)
Key Challenges
Global Radiopharmaceuticals in Nuclear Medicine Production Forecast by Region (2022-2027)
Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Forecast by Type (2022-2027)
Global Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share Forecast by Type (2022-2027)
Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Forecast by Type (2022-2027)
Global Radiopharmaceuticals in Nuclear Medicine Sales Revenue Market Share Forecast by Type (2022-2027)
Global Radiopharmaceuticals in Nuclear Medicine Sales Price Forecast by Type (2022-2027)
Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume Forecast by Application (2022-2027)
Global Radiopharmaceuticals in Nuclear Medicine Consumption Value Forecast by Application (2022-2027)
North America Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027 by Country
East Asia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027 by Country
Europe Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027 by Country
South Asia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027 by Country
Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027 by Country
Middle East Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027 by Country
Africa Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027 by Country
Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027 by Country
South America Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027 by Country
Rest of the world Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027 by Country
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type: 2021 VS 2027
Diagnostic Radiopharmaceuticals Features
Therapy Radiopharmaceuticals Features
Enriched Stable Isotopes Features
Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application: 2021 VS 2027
Diagnostic Application Case Studies
Therapeutic Application Case Studies
Research Case Studies
Pharmaceutical Case Studies
Radiopharmaceuticals in Nuclear Medicine Report Years Considered
Global Radiopharmaceuticals in Nuclear Medicine Market Status and Outlook (2016-2027)
North America Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
East Asia Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
South Asia Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
South America Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Middle East Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Africa Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Oceania Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
South America Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
Rest of the World Radiopharmaceuticals in Nuclear Medicine Revenue (Value) and Growth Rate (2016-2027)
North America Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
East Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
South Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Oceania Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
South America Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
Rest of the World Radiopharmaceuticals in Nuclear Medicine Sales Volume Growth Rate (2016-2021)
North America Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
North America Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries in 2021
United States Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Canada Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Mexico Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
East Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
East Asia Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries in 2021
China Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Japan Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
South Korea Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Europe Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
Europe Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Region in 2021
Germany Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
United Kingdom Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
France Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Italy Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Russia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Spain Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Netherlands Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Switzerland Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Poland Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
South Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
South Asia Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries in 2021
India Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Pakistan Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Bangladesh Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries in 2021
Indonesia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Thailand Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Singapore Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Malaysia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Philippines Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Vietnam Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Myanmar Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Middle East Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
Middle East Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries in 2021
Turkey Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Iran Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
United Arab Emirates Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Israel Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Iraq Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Qatar Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Kuwait Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Oman Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Africa Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
Africa Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries in 2021
Nigeria Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
South Africa Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Egypt Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Algeria Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Morocco Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Oceania Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries in 2021
Australia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
New Zealand Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
South America Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
South America Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries in 2021
Brazil Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Argentina Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Columbia Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Chile Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Venezuelal Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Peru Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Puerto Rico Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Ecuador Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Rest of the World Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate
Rest of the World Radiopharmaceuticals in Nuclear Medicine Consumption Market Share by Countries in 2021
Kazakhstan Radiopharmaceuticals in Nuclear Medicine Consumption and Growth Rate (2016-2021)
Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Type in 2021
Sales Revenue Market Share of Radiopharmaceuticals in Nuclear Medicine by Type in 2021
Global Radiopharmaceuticals in Nuclear Medicine Consumption Volume Market Share by Application in 2021
Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Specification
Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Specification
Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Specification
Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Specification
GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Specification
IBA Group Radiopharmaceuticals in Nuclear Medicine Product Specification
Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Specification
Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Specification
Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Specification
Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Specification
Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Specification
Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Specification
Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Specification
Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Specification
Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Specification
Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Specification
Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Specification
Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medicine
Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
Channels of Distribution
Distributors Profiles
Porter's Five Forces Analysis
Global Radiopharmaceuticals in Nuclear Medicine Production Capacity Growth Rate Forecast (2022-2027)
Global Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Global Radiopharmaceuticals in Nuclear Medicine Price and Trend Forecast (2016-2027)
North America Radiopharmaceuticals in Nuclear Medicine Production Growth Rate Forecast (2022-2027)
North America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
East Asia Radiopharmaceuticals in Nuclear Medicine Production Growth Rate Forecast (2022-2027)
East Asia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Europe Radiopharmaceuticals in Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Europe Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
South Asia Radiopharmaceuticals in Nuclear Medicine Production Growth Rate Forecast (2022-2027)
South Asia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Southeast Asia Radiopharmaceuticals in Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Middle East Radiopharmaceuticals in Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Middle East Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Africa Radiopharmaceuticals in Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Africa Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Oceania Radiopharmaceuticals in Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Oceania Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
South America Radiopharmaceuticals in Nuclear Medicine Production Growth Rate Forecast (2022-2027)
South America Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
Rest of the World Radiopharmaceuticals in Nuclear Medicine Production Growth Rate Forecast (2022-2027)
Rest of the World Radiopharmaceuticals in Nuclear Medicine Revenue Growth Rate Forecast (2022-2027)
North America Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027
East Asia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027
Europe Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027
South Asia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027
Southeast Asia Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027
Middle East Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027
Africa Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027
Oceania Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027
South America Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027
Rest of the world Radiopharmaceuticals in Nuclear Medicine Consumption Forecast 2022-2027
Bottom-up and Top-down Approaches for This Report
By Market Vendors:
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Why Choose Us
- Extensive Library of Reports.
- Identify the clients' needs.
- Pragmatic Research Approach.
- Clarity on Market Scenarios.
- Tailor-Made Solutions.
- Expert Analysts Team.
- Competitive and Fair Prices.
Clientele
Thank you
Xcellent Insights has received your query!